CU23720A3 - POLYINOSINIC ACID-POLYTIDYLIC ACID-BASED ADJUTIVE - Google Patents
POLYINOSINIC ACID-POLYTIDYLIC ACID-BASED ADJUTIVEInfo
- Publication number
- CU23720A3 CU23720A3 CU20070269A CU20070269A CU23720A3 CU 23720 A3 CU23720 A3 CU 23720A3 CU 20070269 A CU20070269 A CU 20070269A CU 20070269 A CU20070269 A CU 20070269A CU 23720 A3 CU23720 A3 CU 23720A3
- Authority
- CU
- Cuba
- Prior art keywords
- acid
- adjuvant
- produce
- immune response
- polytidylic
- Prior art date
Links
- 239000002671 adjuvant Substances 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 5
- 230000028993 immune response Effects 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención proporciona una composición adyuvante polinucleotídica y métodos de uso para producir una respuesta inmune. La presente invención también proporciona una composición inmunogénica que comprende la composición adyuvante polinucleotídica junto con un antígeno (por ejemplo, como en una vacuna). Las composiciones adyuvantes de la invención tienen propiedades físicas particulares (por ejemplo peso molecular, concentración y ph) lo cual conduce a la necesidad de un adyuvante seguro para producir una mejor respuesta inmune. La presente invención contempla además métodos de uso de esas composiciones adyuvantes, particularmente para producir una respuesta inmune a un compuesto antigénico.The present invention provides a polynucleotide adjuvant composition and methods of use to produce an immune response. The present invention also provides an immunogenic composition comprising the polynucleotide adjuvant composition together with an antigen (for example, as in a vaccine). The adjuvant compositions of the invention have particular physical properties (eg molecular weight, concentration and ph) which leads to the need for a safe adjuvant to produce a better immune response. The present invention further contemplates methods of using these adjuvant compositions, particularly to produce an immune response to an antigenic compound.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070269A CU23720A3 (en) | 2007-12-06 | 2007-12-06 | POLYINOSINIC ACID-POLYTIDYLIC ACID-BASED ADJUTIVE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070269A CU23720A3 (en) | 2007-12-06 | 2007-12-06 | POLYINOSINIC ACID-POLYTIDYLIC ACID-BASED ADJUTIVE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23720A3 true CU23720A3 (en) | 2011-10-14 |
Family
ID=45000040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20070269A CU23720A3 (en) | 2007-12-06 | 2007-12-06 | POLYINOSINIC ACID-POLYTIDYLIC ACID-BASED ADJUTIVE |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23720A3 (en) |
-
2007
- 2007-12-06 CU CU20070269A patent/CU23720A3/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL187616A0 (en) | Polyinosinic acid-polycytidylic acid-based adjuvant | |
| MY150706A (en) | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
| MX375202B (en) | NOVEL ADJUVANT COMPOSITIONS. | |
| EA201070200A1 (en) | COMPOSITIONS CONTAINING PNEUMOCOCCAL ANTIGENS | |
| BRPI1013780B8 (en) | IMMUNOGENIC COMPOSITION USEFUL FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS, ITS PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION | |
| CL2018000319A1 (en) | Oil based adjuvants (application division 201600650) | |
| MY143347A (en) | Mucosal immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
| ECSP12011685A (en) | DIRECTED IMMUNOCATE PLAYERS | |
| EA201001491A1 (en) | REPLICATION-DEFECT VACCINES AND VACCINE VECTORS AGAINST FLAVIVIRUSS | |
| TR201802380T4 (en) | Vaccines containing benzonaphthyridine. | |
| BR112015008417A2 (en) | immunogenic composition and vaccine | |
| BR112016002354A2 (en) | immunogenic composition, methods to protect a baby against infection or disease and to evoke an immune response, vaccination regimen, and | |
| BR112015022582A2 (en) | nucleic acid molecule, plasmid, vaccine, and use of a plasmid | |
| MX2015007753A (en) | Vaccine composition for naive subjects. | |
| MX2016016746A (en) | Dual adjuvant vaccine compositions, preparation and uses. | |
| BR112018015893A2 (en) | cancer vaccines and treatment methods using the same | |
| MX2017009306A (en) | VACCINE AGAINST FEVERY FEVER. | |
| PL404247A1 (en) | LOS oligosugar Bordetella pertussis and pertussis toxin and its use in the prevention and treatment of infections caused by Bordetella pertussis | |
| AR073967A1 (en) | PEPTIDO-EPITOPE RAB6KIFL / KIF20A AND VACCINES CONTAINING THE SAME | |
| WO2012103444A3 (en) | Immunogenic compositions and reagents for preparing | |
| EA201200538A1 (en) | ARABINOGALAKTAN TO IMPROVE ACQUIRED IMMUNE RESPONSE | |
| CU23720A3 (en) | POLYINOSINIC ACID-POLYTIDYLIC ACID-BASED ADJUTIVE | |
| CO6511241A2 (en) | IMMUNIZATION SCHEME FOR HETEROLOGICAL AWARENESS-REINFORCEMENT | |
| UA104138C2 (en) | Novel adjuvant compositions | |
| CY1117230T1 (en) | COMPOSITIONS FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS |